These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 15220015)

  • 1. Randomized, open-label, two-period crossover comparison of the pharmacokinetic and pharmacodynamic properties of two amlodipine formulations in healthy adult male Korean subjects.
    Park JY; Kim KA; Lee GS; Park PW; Kim SL; Lee YS; Lee YW; Shin EK
    Clin Ther; 2004 May; 26(5):715-23. PubMed ID: 15220015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic and pharmacodynamic characteristics of a new S-amlodipine formulation in healthy Korean male subjects: a randomized, open-label, two-period, comparative, crossover study.
    Park JY; Kim KA; Park PW; Lee OJ; Ryu JH; Lee GH; Ha MC; Kim JS; Kang SW; Lee KR
    Clin Ther; 2006 Nov; 28(11):1837-47. PubMed ID: 17213004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and bioequivalence evaluation of two formulations of 10-mg amlodipine besylate: an open-label, single-dose, randomized, two-way crossover study in healthy Chinese male volunteers.
    Liu Y; Jia J; Liu G; Li S; Lu C; Liu Y; Yu C
    Clin Ther; 2009 Apr; 31(4):777-83. PubMed ID: 19446150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative pharmacokinetic and pharmacodynamic characteristics of amlodipine besylate and amlodipine nicotinate in healthy subjects.
    Park JY; Kim KA; Park PW; Lee OJ; Kim JS; Lee GH; Ha MC; Park JH; O MJ; Ryu JH
    Int J Clin Pharmacol Ther; 2006 Dec; 44(12):641-7. PubMed ID: 17190374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacodynamic (hemodynamic) and pharmacokinetic comparisons of S-amlodipine gentisate and racemate amlodipine besylate in healthy Korean male volunteers: two double-blind, randomized, two-period, two-treatment, two-sequence, double-dummy, single-dose crossover studies.
    Kim BH; Kim JR; Kim MG; Kim KP; Lee BY; Jang IJ; Shin SG; Yu KS
    Clin Ther; 2010 Jan; 32(1):193-205. PubMed ID: 20171424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparisons of the pharmacokinetics and tolerability of fixed-dose combinations of amlodipine besylate/losartan and amlodipine camsylate/losartan in healthy subjects: a randomized, open-label, single-dose, two-period, two-sequence crossover study.
    Choi Y; Lee S; Cho SM; Kang WH; Nam KY; Jang IJ; Yu KS
    Drug Des Devel Ther; 2016; 10():3021-3028. PubMed ID: 27703330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative bioavailability and pharmacokinetics of a new sibutramine formulation in healthy male subjects: a randomized, open-label, two-period, comparative crossover study.
    Park JY; Kim KA; Park PW; Suh KH; Lee GS
    Clin Ther; 2004 Dec; 26(12):2092-101. PubMed ID: 15823773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic comparison of 2 fixed-dose combination tablets of amlodipine and valsartan in healthy male Korean volunteers: a randomized, open-label, 2-period, single-dose, crossover study.
    Kim Y; Son M; Lee D; Roh H; Son H; Chae D; Bahng MY; Park K
    Clin Ther; 2013 Jul; 35(7):934-40. PubMed ID: 23870605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioequivalence Study of a New Fixed-dose Combination Tablet Containing S-Amlodipine Nicotinate and Olmesartan Medoxomil in Healthy Korean Male Subjects.
    Oh MJ; Hwang HH; Kim HG; Lee GH; Cho YS; Lee SY; Kang SY; Cho KH; Lee YY; Lee YJ; Jang CG; Lee SY
    Clin Ther; 2017 Jul; 39(7):1371-1379. PubMed ID: 28625505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioequivalence and pharmacokinetic comparison of two mycophenolate mofetil formulations in healthy Chinese male volunteers: an open-label, randomized-sequence, single-dose, two-way crossover study.
    Zhang Q; Tao Y; Zhu Y; Zhu D
    Clin Ther; 2010 Jan; 32(1):171-8. PubMed ID: 20171422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
    Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
    Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic and pharmacodynamic profiles of a fixed-dose combination of olmesartan medoxomil and amlodipine in healthy Chinese males and females.
    Chen X; Hu P; Jiang J; Liu T; Zhong W; Liu H; Zhao Q
    Clin Drug Investig; 2012 Dec; 32(12):783-90. PubMed ID: 23160920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic properties and bioequivalence of two compound formulations of 1500 mg ampicillin (1167 mg)/probenecid (333 mg): a randomized-sequence, single-dose, open-label, two-period crossover study in healthy Chinese male volunteers.
    Wu H; Liu M; Wang S; Feng W; Yao W; Zhao H; Wei M
    Clin Ther; 2010 Mar; 32(3):597-606. PubMed ID: 20399996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic comparison of amlodipine adipate/valsartan fixed-dose combination with amlodipine besylate/valsartan fixed-dose combination in healthy volunteers.
    Nam JH; Oh M; Kim HJ; Han SK; Kim EJ; Song GS; Kim EY; Shin JG; Ghim JL; Kim HS
    Int J Clin Pharmacol Ther; 2015 Jan; 53(1):66-74. PubMed ID: 25034618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic properties and bioequivalence of two formulations of arbidol: an open-label, single-dose, randomized-sequence, two-period crossover study in healthy Chinese male volunteers.
    Liu MY; Wang S; Yao WF; Wu HZ; Meng SN; Wei MJ
    Clin Ther; 2009 Apr; 31(4):784-92. PubMed ID: 19446151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic and Safety Profiles of a Fixed-Dose Combination of Amlodipine, Valsartan, and Atorvastatin: A 3-Period Replicate Crossover Study.
    Kim S; Ko JW; Kim JR
    Clin Pharmacol Drug Dev; 2020 Apr; 9(3):386-394. PubMed ID: 31373174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics, tolerability, and safety of the single oral administration of AGSAV301 vs Exforge: a randomized crossover study of healthy male volunteers.
    Choi HY; Kim YH; Kim MJ; Noh YH; Lee SH; Bae KS; Lim HS
    Am J Cardiovasc Drugs; 2014 Feb; 14(1):63-72. PubMed ID: 24174172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioequivalence and pharmacokinetic evaluation of two formulations of risperidone 2 mg : an open-label, single-dose, fasting, randomized-sequence, two-way crossover study in healthy male Chinese volunteers.
    Liu Y; Zhang MQ; Jia JY; Liu YM; Liu GY; Li SJ; Wang W; Weng LP; Yu C
    Drugs R D; 2013 Mar; 13(1):29-36. PubMed ID: 23322527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioequivalence and pharmacokinetic comparison of a single 200-mg dose of meclofenoxate hydrochloride capsule and tablet formulations in healthy Chinese adult male volunteers: a randomized sequence, open-label, two-period crossover study.
    Zou JJ; Ji HJ; Wu DW; Yao J; Hu Q; Xiao DW; Wang GJ
    Clin Ther; 2008 Sep; 30(9):1651-7. PubMed ID: 18840370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic comparison of a fixed-dose combination versus concomitant administration of fimasartan, amlodipine, and rosuvastatin using partial replicated design in healthy adult subjects.
    Oh M; Ghim JL; Park SE; Kim EY; Shin JG
    Drug Des Devel Ther; 2018; 12():1157-1164. PubMed ID: 29780236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.